Yasin Senel

Yasin Senel is a skilled professional in the pharmaceutical and biotechnology sectors, currently serving as a Team Leader at AGC Biologics since November 2023 and a Board Member at KAB since September 2022. Previously, Yasin held roles at Novo Nordisk from October 2019 to November 2023 as a QA Professional and QP delegate, ensuring compliance and quality in clinical trials and contributing to various facets of quality assurance. Yasin has a strong background in environmental chemistry, having worked as an Environmental Chemist and QA delegate at Region Hovedstadens Apotek, where responsibilities included environmental monitoring and adherence to regulatory standards. Yasin also has experience as a founder of Kandyman and holds a Master of Science in Pharmacy from the University of Copenhagen, complemented by studies at Utrecht University and the University of Bonn.